by axia_82w8h3 | Sep 1, 2021
Comments on the FDA’s Drug Supply Chain Security Act, an important area of focus for our Institute There is a need for end-to-end trust verification for the entire value chain to enhance patient safety, patient health, product quality, and product authenticity by...
Recent Comments